Evidence map›Paper›PMID 23208079›Full record

ArticleJournal of innate immunity2013

Enhancement of antigen-specific immunoglobulin G responses by anti-CD48.

Dorothy Yuan, Yuhong Guo, Suwannee Thet

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Roles of CD48 in regulating immunity and tolerance.Clinical immunology (Orlando, Fla.) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dorothy YuanDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX 75230, USA. dorothy.yuan @ utsouthwestern.edu
Yuhong Guo
Suwannee Thet
Southwestern Medical CenterThe University of Texas Southwestern Medical Center · US

Funding

The role of activated NK cells in a mouse model of lupus erythematosusR01AI069253 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI YUAN, DOROTHY C · 2006 to 2010
$1.9M
NIAID NIH HHS R01 AI069253
6 · The paper itself

Abstract

CD48 is a glycosylphosphatidylinositol-anchored protein expressed ubiquitously on many cell types. Despite the poor ability to signal on its own, CD48 can activate cells via interaction with its counter receptors CD2 and CD244 as well as influence the function of other cell surface molecules by costimulatory activities. We show, herein, that injection of anti-CD48 antibodies into mice can augment the antibody response to a T-independent antigen, NP-Ficoll, that is representative of antigenic determinants expressed on the surface of various pathogens, such as Streptococcus pneumoniae. In C57BL/6 mice, enhancement of the response is dependent on natural killer (NK) cells as well as on the presence of CD2 and CD244, ligands for CD48, suggesting a requirement for direct interaction between NK and B cells. Interestingly, in this case, despite a similar augmentation by anti-CD48 in BALB/C mice, the response is independent of NK or T cells, suggesting that help for this response can be derived from other innate cell types. These results provide a pathway by which CD48, when appropriately activated, can influence the course of an antigen-specific antibody response via the innate system.

Indexed as

AnimalsAntibody FormationAntigens, BacterialAntigens, CDB-LymphocytesCD2 AntigensCD48 AntigenCell CommunicationCells, CulturedImmunoglobulin GKiller Cells, NaturalLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C57BLReceptors, ImmunologicAntigens, BacterialAntigens, CDCd244a protein, mouseCD2 AntigensCD48 AntigenCd48 protein, mouseImmunoglobulin GReceptors, ImmunologicSignaling Lymphocytic Activation Molecule Family

Identifiers

PMID23208079
PMCPMC6741465
OpenAlexW2024624368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.